UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CONMED
CNMD
$1.47B
| $793K | ﹤0.01% |
15,699
+300
| +2% | +$14.7K |
|
1677
Healthcare Services Group
HCSG
$1.53B
| $790K | ﹤0.01% |
24,598
+1,100
| +5% | +$35.5K |
|
1678
Unifirst Corp
UNF
$5.25B
| $789K | ﹤0.01% |
6,700
+100
| +2% | +$11.8K |
|
1679
Chemed
CHE
$7.22B
| $788K | ﹤0.01% |
6,600
+300
| +5% | +$33.3K |
|
|
RWT
1680
Redwood Trust
RWT
$594M
| $786K | ﹤0.01% |
43,997
+8,300
| +23% | +$161K |
|
1681
Neogen
NEOG
$2.5B
| $785K | ﹤0.01% |
44,795
+1,600
| +4% | +$29.3K |
|
|
ALEX
1682
DELISTED
Alexander & Baldwin
ALEX
| $777K | ﹤0.01% |
17,999
+900
| +5% | +$35.7K |
|
|
PMCS
1683
DELISTED
P M C SIERRA INC
PMCS
| $777K | ﹤0.01% |
83,694
+4,400
| +6% | +$40.6K |
|
|
MDP
1684
DELISTED
Meredith Corporation
MDP
| $775K | ﹤0.01% |
13,899
+700
| +5% | +$37.6K |
|
|
EFII
1685
DELISTED
Electronics for Imaging
EFII
| $772K | ﹤0.01% |
18,498
+800
| +5% | +$31.7K |
|
|
CMO
1686
DELISTED
Capstead Mortgage Corp.
CMO
| $771K | ﹤0.01% |
65,496
-10,400
| -14% | -$125K |
|
1687
Insight Enterprises
NSIT
$4.38B
| $770K | ﹤0.01% |
26,999
+800
| +3% | +$20.6K |
|
1688
American States Water
AWR
$3.46B
| $764K | ﹤0.01% |
19,151
+700
| +4% | +$27.8K |
|
|
ISIL
1689
DELISTED
Intersil Corp
ISIL
| $762K | ﹤0.01% |
53,195
+4,600
| +9% | +$68.3K |
|
|
FNFV
1690
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $761K | ﹤0.01% |
53,976
-39,093
| -42% | -$528K |
|
1691
Selective Insurance
SIGI
$5.73B
| $758K | ﹤0.01% |
26,098
+2,600
| +11% | +$71.6K |
|
|
LCI
1692
DELISTED
Lannett Company, Inc.
LCI
| $758K | ﹤0.01% |
2,800
+125
| +5% | +$28.4K |
|
1693
FTI Consulting
FCN
$4.18B
| $757K | ﹤0.01% |
20,199
+900
| +5% | +$34K |
|
1694
Enerpac Tool Group
EPAC
$1.93B
| $756K | ﹤0.01% |
31,856
+1,300
| +4% | +$31.9K |
|
1695
Embotelladora Andina Series B
AKO.B
$4.95B
| $754K | ﹤0.01% |
50,100
| – | – |
|
1696
Matthews International
MATW
$739M
| $752K | ﹤0.01% |
14,600
+300
| +2% | +$14.5K |
|
1697
Clearway Energy Class C
CWEN
$6.7B
| $751K | ﹤0.01% |
29,600
+1,400
| +5% | +$36.4K |
|
1698
Korn Ferry
KFY
$4.28B
| $749K | ﹤0.01% |
22,798
+900
| +4% | +$27.3K |
|
1699
Greif
GEF
$5.04B
| $747K | ﹤0.01% |
19,025
+700
| +4% | +$28.6K |
|
1700
Lazard
LAZ
$4.31B
| $747K | ﹤0.01% |
14,200
| – | – |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.